Rebuttal From Dr Prasse

Chest. 2019 Aug;156(2):208-209. doi: 10.1016/j.chest.2019.03.029.

Author

Affiliation

¹ Hannover Medical School and Deutsches Zentrum für Lungenforschung (DZL), Biomedical Research in Endstage and Obstructive Lung Disease (BREATH), and the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany. Electronic address: prasse.antje@mh-hannover.de.

PMID: 31395257
DOI: 10.1016/j.chest.2019.03.029

No abstract available

Publication types

Editorial
Comment

MeSH terms

Genetic Markers
Humans
Lung Diseases, Interstitial* / diagnosis
Pulmonary Fibrosis* / diagnosis

Substances

Genetic Markers